Discovery of Highly Potent G Protein-Biased Bisamide Kappa Opioid Receptor Agonists.
Through a structure-activity relationship (SAR) study of a bisamide-containing lead series, a group of KOR agonists with subnanomolar potency in G protein signaling and several with bias for G protein activation over βarrestin2 recruitment are generated.